Clinical trial · Interventional
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Cancer Screening | — | UNRESOLVED | — |
| HPV DNA | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DADA LINK | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- DADA-LINK Integrated Care Package: HPV Self-Sampling, Care Navigation, and mHealth support
- description
- Intervention facilities will receive the DADA-LINK multi-component integrated care package comprised of HPV self-sampling, care navigation, and mHealth support.
- interventionNames
- Behavioral: DADA LINK
- type
- NO_INTERVENTION
- label
- Routine standard of care for cervical cancer screening, linkage and treatment
- description
- Clinics randomized to the control arm will continue with usual care practices for cervical cancer screening, triage, and treatment
Primary outcomes (2)
- measure
- Primary implementation outcome: Cervical cancer screening uptake
- timeFrame
- 1 day (on the day of clinic visit)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 49 Years
Show eligibility criteria text
Inclusion Criteria: \- Women ages 25-49 years Exclusion Criteria: * Pregnant women * Women ≤6 weeks postpartum * Women already confirmed to have cervical cancer
References
Publications (0)
Data not yet available